Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study — a prospective single-arm intervention trial

Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study — a prospective single-arm intervention trial

Abstract Background Hepatitis C virus (HCV) is the leading indication for liver transplantation and liver-related mortality. The development of direct-acting antivirals (DAA) and a simplified treatment algorithm with a > 97% cure rate should make global elimination of HCV an achievable goal. Yet,...

Full description

Bibliographic Details
Main Authors: Anmol Desai, Lauren O’Neal, Kia Reinis, Patrick Chang, Cristal Brown, Michael Stefanowicz, Audrey Kuang, Deepak Agrawal, Darlene Bhavnani, Tim Mercer
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Pilot and Feasibility Studies
Subjects:
Hepatitis C virus
Homelessness
Intravenous drug use
Implementation science
Simplified treatment
Site-specific treatment
Online Access:https://doi.org/10.1186/s40814-023-01311-4

Internet

https://doi.org/10.1186/s40814-023-01311-4

Similar Items